Cryoablation of Intercostal Nerves for Pain Management in Early Postoperative Period in Patients With Minimally Invasive Mitral Valve Surgery

Launched by MESHALKIN RESEARCH INSTITUTE OF PATHOLOGY OF CIRCULATION · May 30, 2024

Keywords

ClinConnect Summary

This clinical trial is looking at a treatment called cryoablation, which is a technique that uses cold to reduce pain, specifically in patients recovering from minimally invasive mitral valve surgery. The main goal of the study is to see if this treatment can help patients feel less pain after their surgery and reduce the need for opioid pain medications. By doing this study, the researchers hope to gather important information that could lead to a larger trial in the future.

To participate in this trial, patients need to provide written consent and have undergone minimally invasive mitral valve surgery. They should not be pregnant, on certain medications like antidepressants, or have conditions that might affect how they feel pain. Participants will be randomly assigned to receive either the cryoablation treatment or standard pain management. If you’re interested in joining the study, you can expect to be closely monitored for your pain levels and medication use during your recovery.

Gender

ALL

Eligibility criteria

• Inclusion criteria:
• • Written informed consent;
• • Minimally invasive mitral valve surgery.
• Non-inclusion criteria:
• • patient refusal;
• • pregnancy;
• • treatment with antidepressants or epileptic drugs;
• • depression, which can significantly affect the perception of pain;
• • chronic use of analgesics;
• • participation in competing randomized clinical trials.
• Exclusion criteria:
• • - Extended mechanical ventilation, more than 12 hours.